Disease information by primary method of recurrence detection
| All patients | Tumor marker | Scan | Surgery | Symptoms | P value | |
| n=147 | n=46 | n=81 | n=3 | n=17 | ||
| Stage | 0.594 | |||||
| I | 4 (2.7%) | 0 (0%) | 2 (2.5%) | 0 (0%) | 2 (12%) | |
| II | 3 (2.0%) | 1 (2.2%) | 2 (2.5%) | 0 (0%) | 0 (0%) | |
| III | 64 (44%) | 20 (43%) | 35 (43%) | 1 (33%) | 8 (47%) | |
| IV | 76 (52%) | 25 (54%) | 42 (52%) | 2 (67%) | 7 (41%) | |
| Histology | 0.304 | |||||
| Carcinosarcoma | 5 (3.4%) | 1 (2.2%) | 3 (3.7%) | 0 (0%) | 1 (5.9%) | |
| Clear cell | 10 (6.8%) | 1 (2.2%) | 8 (9.9%) | 0 (0%) | 1 (5.9%) | |
| High-grade serous | 126 (86%) | 41 (89%) | 69 (85%) | 3 (100%) | 13 (76%) | |
| Low-grade serous | 2 (1.4%) | 1 (2.2%) | 1 (1.2%) | 0 (0%) | 0 (0%) | |
| Mixed | 2 (1.4%) | 1 (2.2%) | 0 (0%) | 0 (0%) | 1 (5.9%) | |
| Other | 2 (1.4%) | 1 (2.2%) | 0 (0%) | 0 (0%) | 1 (5.9%) | |
| Chemotherapy type | 1.000 | |||||
| Neoadjuvant and adjuvant | 68 (46%) | 21 (46%) | 38 (47%) | 1 (33%) | 8 (47%) | |
| Postoperative | 79 (54%) | 25 (54%) | 43 (53%) | 2 (67%) | 9 (53%) |